Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Completes $80M Acquisition of Rules-Based Medicine

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Myriad Genetics today said it has completed its $80 million purchase of Rules-Based Medicine.

RBM will remain based in Austin, Texas and will operate as a wholly owned subsidiary of Myriad. RBM discovers biomarkers for pharmaceutical and biotechnology firms using its multiplex immunoassay technology. It will continue its collaborations with pharma partners in companion diagnostic discovery and carry out internal research projects, Myriad said.

When the deal was announced last month, Myriad said the purchase would expand its product portfolio into new disease areas, including psychiatric disorders, infectious diseases, and inflammatory conditions, and add eight molecular diagnostic product candidates to Myriad's pipeline.

Privately-held Rules-Based Medicine had 2010 revenues of around $25 million and has approximately 160 employees. During Myriad's fiscal fourth quarter ending June 30, RBM is anticipated to contribute $2 million in revenues.

In early morning trading today on the Nasdaq shares of Myriad were down 2 percent at $24.98.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.